Wells Pharmacy Network company profile: what is public, what is not

As of June 2026, Wells Pharmacy Network's public site does not prominently disclose who owns the company, the names of its leadership, whether it has raised outside funding, a specific headquarters address, or how many clinics use it. Order volumes and customer counts are also not published. Where a fact is not in Wells's public materials, it is undisclosed rather than estimated here.

This is common for privately held pharmacies and compounders and is not, by itself, a disqualifier. It does mean a clinic's due diligence has to come from direct requests rather than the website. Wells is a licensed 503A and 503B pharmacy with a verifiable registration — the compounding credentials are the primary trust signal, and those can be confirmed through FDA and state licensing databases.

Because corporate facts are not prominent on the public site, request them in the account qualification process: ask which legal entity you are contracting with and what the contract and cancellation terms are. Ask for state licensure confirmation for the states your patients are in, and request copies of any relevant certificates of analysis or PCAB or USP compliance documentation. For 503B, confirm the FDA-registered facility number. Ask for references from similar clinics currently using WellsPx3 for the same formulary mix.

On the parts you can verify yourself, confirm the pharmacy is licensed by your state board of pharmacy and that wellsrx.com, orders.wellsrx.com (WellsPx3), and wplscripts.wellsrx.com (WPNScripts) are the official Wells properties. For a transparent point of comparison, Fizy Health publishes its model openly — pass-through per-vial 503A pricing before checkout, a disclosed facilitation fee, LegitScript-certified partners — which is the kind of visibility to look for when a vendor's corporate details are thin.